REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 21 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -50.0% | 1,750 | +6.1% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 1,650 | -5.5% | 0.00% | – |
| Q3 2018 | $3,000 | +50.0% | 1,746 | +5.8% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 1,650 | -4.6% | 0.00% | – |
| Q1 2018 | $2,000 | -33.3% | 1,729 | +4.8% | 0.00% | – |
| Q4 2017 | $3,000 | -72.7% | 1,650 | -55.2% | 0.00% | – |
| Q2 2017 | $11,000 | – | 3,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 169,901 | $411,000 | 0.03% |
| Benin Management CORP | 14,300 | $35,000 | 0.01% |
| Northeast Financial Consultants Inc | 15,000 | $36,000 | 0.01% |
| WEDBUSH SECURITIES INC | 25,500 | $62,000 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 49,167 | $119,000 | 0.00% |
| Renaissance Technologies | 344,299 | $833,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,238 | $20,000 | 0.00% |
| NORTHERN TRUST CORP | 47,859 | $116,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 28 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 146,083 | $353,000 | 0.00% |